We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+15.94%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$1.73B
AUM Growth
+$152M
Cap. Flow
-$38.6M
Cap. Flow %
-2.23%
Top 10 Hldgs %
25.39%
Holding
270
New
10
Increased
28
Reduced
188
Closed
10

Top Buys

Rank Stock Value
1
ESTA icon
Establishment Labs
ESTA
+$11.2M
2
PBH icon
Prestige Consumer Healthcare
PBH
+$6.68M
3
VRNA
Verona Pharma
VRNA
+$6.54M
4
ADUS icon
Addus HomeCare
ADUS
+$3.51M
5
IWO icon
iShares Russell 2000 Growth ETF
IWO
+$2.65M

Top Sells

Rank Stock Value
1
BBBY
Bed Bath & Beyond
BBBY
+$11.2M
2
LRN icon
Stride
LRN
+$9.83M
3
NXGN
NextGen Healthcare, Inc. Common Stock
NXGN
+$9.14M
4
AX icon
Axos Financial
AX
+$5.93M
5
DEN
Denbury Inc.
DEN
+$3.51M

Sector Composition

Rank Sector Weight
1 Healthcare 30.1%
2 Technology 23.78%
3 Industrials 19.23%
4 Consumer Discretionary 6.36%
5 Communication Services 6.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EBAY icon
226
eBay
EBAY
$47.9B
$785K 0.05%
18,006
-850
-5% -$35.2K
DLB icon
227
Dolby
DLB
$5.82B
$781K 0.05%
9,060
-417
-4% -$35.2K
IEX icon
228
IDEX
IEX
$17.2B
$770K 0.04%
3,546
– –
KBR icon
229
KBR
KBR
$4.83B
$751K 0.04%
13,559
-28
-0.2% -$1.54K
ABBV icon
230
AbbVie
ABBV
$438B
$749K 0.04%
4,836
– –
DVN icon
231
Devon Energy
DVN
$49.9B
$743K 0.04%
16,402
– –
CIEN icon
232
Ciena
CIEN
$54.9B
$738K 0.04%
16,397
– –
CDW icon
233
CDW
CDW
$17.1B
$718K 0.04%
3,158
-9
-0.3% -$1.91K
TDY icon
234
Teledyne Technologies
TDY
$32B
$647K 0.04%
1,450
– –
GBCI icon
235
Glacier Bancorp
GBCI
$6.35B
$643K 0.04%
15,565
-1,080
-6% -$36.8K
TVTX icon
236
Travere Therapeutics
TVTX
$5.74B
$632K 0.04%
70,260
-8,102
-10% -$59K
FMC icon
237
FMC
FMC
$1.31B
$607K 0.04%
9,635
-1,581
-14% -$91.7K
YMAB
238
DELISTED
Y-mAbs Therapeutics
YMAB
$583K 0.03%
85,513
-5,736
-6% -$33.2K
ABT icon
239
Abbott
ABT
$188B
$565K 0.03%
5,136
– –
ALKS icon
240
Alkermes
ALKS
$8.29B
$563K 0.03%
+20,302
New +$527K
CVX icon
241
Chevron
CVX
$382B
$557K 0.03%
3,737
– –
CXT icon
242
Crane NXT
CXT
$2.96B
$552K 0.03%
9,710
– –
BRK.A icon
243
Berkshire Hathaway Class A
BRK.A
$1.14T
$543K 0.03%
1
– –
AAPL icon
244
Apple
AAPL
$4.5T
$539K 0.03%
2,800
– –
NOTV
245
DELISTED
Inotiv
NOTV
$517K 0.03%
140,749
-11,241
-7% -$28.4K
SCPH
246
DELISTED
scPharmaceuticals
SCPH
$508K 0.03%
81,004
-6,067
-7% -$34.7K
J icon
247
Jacobs Solutions
J
$17.2B
$460K 0.03%
4,286
– –
SYY icon
248
Sysco
SYY
$40.1B
$406K 0.02%
5,552
– –
MCO icon
249
Moody's
MCO
$82.8B
$362K 0.02%
928
– –
JPM icon
250
JPMorgan Chase
JPM
$956B
$350K 0.02%
2,058
– –
7 8 9
10
11

Similar funds

RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
IL
Investure LLC Charlottesville, Virginia $2.04B AUM 15.91% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM

Rice Hall James & Associates's Q4 2023 Portfolio in Review

As of Q4 2023, Rice Hall James & Associates held 270 positions worth $1.73B, up 9.7% from $1.57B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Rice Hall James & Associates's Q4 2023 filing shows 10 new, 28 increased, 188 reduced and 10 closed positions. Its largest new stake was Addus HomeCare: 40,418 shares worth $3.75M. The largest sale was Bed Bath & Beyond, an estimated $11.2M.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 28% a quarter earlier, followed by Technology and Industrials.

  • Rice Hall James & Associates's largest Q4 2023 buy was Addus HomeCare: 40,418 shares worth $3.75M.
  • Rice Hall James & Associates added most to Establishment Labs in Q4 2023, an estimated $11.2M increase.
  • Rice Hall James & Associates's biggest Q4 2023 reduction was Bed Bath & Beyond, cutting an estimated $11.2M.
  • Rice Hall James & Associates fully exited NextGen Healthcare, Inc. Common Stock in Q4 2023, selling an estimated $9.14M.
  • Rice Hall James & Associates's ten largest holdings make up 25% of its $1.73B portfolio in Q4 2023.
  • Rice Hall James & Associates opened 10 new positions and closed 10 in Q4 2023.
  • Rice Hall James & Associates's portfolio value rose 9.7% quarter-over-quarter to $1.73B.

Based on Rice Hall James & Associates's 13F filing for Q4 2023, filed 9 Feb 2024.